Drug Shortage Report for SYNJARDY
Report ID | 187800 |
Drug Identification Number | 02456621 |
Brand name | SYNJARDY |
Common or Proper name | SYNJARDY 12.5/1000MG 6X10 |
Company Name | BOEHRINGER INGELHEIM (CANADA) LTD LTEE |
Market Status | MARKETED |
Active Ingredient(s) | METFORMIN HYDROCHLORIDE EMPAGLIFLOZIN |
Strength(s) | 1000MG 12.5MG |
Dosage form(s) | TABLET |
Route of administration | ORAL ORAL |
Packaging size | 6X10 |
ATC code | A10BD |
ATC description | BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS |
Reason for shortage | Other (Please describe in comments) |
Anticipated start date | 2023-03-30 |
Actual start date | |
Estimated end date | 2023-03-30 |
Actual end date | 2023-03-29 |
Shortage status | Avoided shortage |
Updated date | 2023-03-29 |
Company comments | Anticipated Shortage due to Inbound Logistics Delay Averted - No Patient Impact expected due to 2-3 weeks inventory on hand at wholesalers |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 5180 SOUTH SERVICE ROAD BURLINGTON, ONTARIO CANADA L7L 5H4 |
Company contact information | 1800 263 2425 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v4 | 2023-03-29 | French | Compare |
v3 | 2023-03-29 | English | Compare |
v2 | 2023-03-24 | French | Compare |
v1 | 2023-03-24 | English | Compare |
Showing 1 to 4 of 4